Antimicrobial Consumption in England, 2017 to 2021

The UK’s 5-year National Action Plan for Antimicrobial Resistance has an ambition to reduce total antimicrobial consumption, a key driver of antimicrobial resistance, in humans by 15% by 2024, highlighting the need for active surveillance to inform on progression. The English Surveillance Programme...

Full description

Bibliographic Details
Main Authors: Sabine Bou-Antoun, Angela Falola, Holly Fountain, Hanna Squire, Colin S. Brown, Susan Hopkins, Sarah M. Gerver, Alicia Demirjian
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Medical Sciences Forum
Subjects:
Online Access:https://www.mdpi.com/2673-9992/15/1/1
_version_ 1797379875987783680
author Sabine Bou-Antoun
Angela Falola
Holly Fountain
Hanna Squire
Colin S. Brown
Susan Hopkins
Sarah M. Gerver
Alicia Demirjian
author_facet Sabine Bou-Antoun
Angela Falola
Holly Fountain
Hanna Squire
Colin S. Brown
Susan Hopkins
Sarah M. Gerver
Alicia Demirjian
author_sort Sabine Bou-Antoun
collection DOAJ
description The UK’s 5-year National Action Plan for Antimicrobial Resistance has an ambition to reduce total antimicrobial consumption, a key driver of antimicrobial resistance, in humans by 15% by 2024, highlighting the need for active surveillance to inform on progression. The English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) report, Chapter 3, commentates on key national antimicrobial consumption trends, across primary and secondary care in England, between 2017 to 2021. These findings were presented at the ESPAUR Report webinar on 23 November 2022.
first_indexed 2024-03-08T20:30:20Z
format Article
id doaj.art-ce9941c0eed84e97afa75bddf2be4a4f
institution Directory Open Access Journal
issn 2673-9992
language English
last_indexed 2024-03-08T20:30:20Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Medical Sciences Forum
spelling doaj.art-ce9941c0eed84e97afa75bddf2be4a4f2023-12-22T14:28:11ZengMDPI AGMedical Sciences Forum2673-99922023-01-01151110.3390/msf2022015001Antimicrobial Consumption in England, 2017 to 2021Sabine Bou-Antoun0Angela Falola1Holly Fountain2Hanna Squire3Colin S. Brown4Susan Hopkins5Sarah M. Gerver6Alicia Demirjian7United Kingdom Health Security Agency (UKHSA), London NW9 5EQ, UKUnited Kingdom Health Security Agency (UKHSA), London NW9 5EQ, UKUnited Kingdom Health Security Agency (UKHSA), London NW9 5EQ, UKUnited Kingdom Health Security Agency (UKHSA), London NW9 5EQ, UKUnited Kingdom Health Security Agency (UKHSA), London NW9 5EQ, UKUnited Kingdom Health Security Agency (UKHSA), London NW9 5EQ, UKUnited Kingdom Health Security Agency (UKHSA), London NW9 5EQ, UKUnited Kingdom Health Security Agency (UKHSA), London NW9 5EQ, UKThe UK’s 5-year National Action Plan for Antimicrobial Resistance has an ambition to reduce total antimicrobial consumption, a key driver of antimicrobial resistance, in humans by 15% by 2024, highlighting the need for active surveillance to inform on progression. The English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) report, Chapter 3, commentates on key national antimicrobial consumption trends, across primary and secondary care in England, between 2017 to 2021. These findings were presented at the ESPAUR Report webinar on 23 November 2022.https://www.mdpi.com/2673-9992/15/1/1antimicrobial consumptionantibioticantifungalEngland
spellingShingle Sabine Bou-Antoun
Angela Falola
Holly Fountain
Hanna Squire
Colin S. Brown
Susan Hopkins
Sarah M. Gerver
Alicia Demirjian
Antimicrobial Consumption in England, 2017 to 2021
Medical Sciences Forum
antimicrobial consumption
antibiotic
antifungal
England
title Antimicrobial Consumption in England, 2017 to 2021
title_full Antimicrobial Consumption in England, 2017 to 2021
title_fullStr Antimicrobial Consumption in England, 2017 to 2021
title_full_unstemmed Antimicrobial Consumption in England, 2017 to 2021
title_short Antimicrobial Consumption in England, 2017 to 2021
title_sort antimicrobial consumption in england 2017 to 2021
topic antimicrobial consumption
antibiotic
antifungal
England
url https://www.mdpi.com/2673-9992/15/1/1
work_keys_str_mv AT sabinebouantoun antimicrobialconsumptioninengland2017to2021
AT angelafalola antimicrobialconsumptioninengland2017to2021
AT hollyfountain antimicrobialconsumptioninengland2017to2021
AT hannasquire antimicrobialconsumptioninengland2017to2021
AT colinsbrown antimicrobialconsumptioninengland2017to2021
AT susanhopkins antimicrobialconsumptioninengland2017to2021
AT sarahmgerver antimicrobialconsumptioninengland2017to2021
AT aliciademirjian antimicrobialconsumptioninengland2017to2021